[1]
|
Samant, H., Amiri, H.S. and Zibari, G.B. (2021) Addressing the Worldwide Hepatocellular Carcinoma: Epidemiology, Prevention and Management. Journal of Gastrointestinal Oncology, 12, S361-S373.
https://pubmed.ncbi.nlm.nih.gov/34422400/
https://doi.org/10.21037/jgo.2020.02.08
|
[2]
|
Deng, S.S., Solinas, A. and Calvisi, D.F. (2021) Cabozantinib for HCC Treatment, from Clinical Back to Experimental Models. Frontiers in Oncology, 11, Article 756672. https://pubmed.ncbi.nlm.nih.gov/34722310/
https://doi.org/10.3389/fonc.2021.756672
|
[3]
|
Ouyang, T., Kan, X.F. and Zheng, C.S. (2022) Immune Checkpoint Inhibitors for Advanced Hepatocellular Carcinoma: Monotherapies and Combined Therapies. Frontiers in Oncology, 12, Article 898964.
https://pubmed.ncbi.nlm.nih.gov/35785169/
https://doi.org/10.3389/fonc.2022.898964
|
[4]
|
Kim, D.W., Talati, C. and Kim, R. (2017) Hepatocellular Carcinoma (HCC): Beyond Sorafenib—Chemotherapy. Journal of Gastrointestinal Oncology, 8, 256-265. https://doi.org/10.21037/jgo.2016.09.07
|
[5]
|
Ghaziani, T.T. and Dhanasekaran, R. (2021) Recent Progress in Sys-temic Therapy for Hepatocellular Cancer (HCC). Current Treatment Options in Gastroenterology, 19, 351-368. https://pubmed.ncbi.nlm.nih.gov/35530750/
https://doi.org/10.1007/s11938-021-00346-x
|
[6]
|
Zheng, K., Cubero, F. and Nevzorova, Y. (2017) c-MYC—Making Liver Sick: Role of c-MYC in Hepatic Cell Function, Homeostasis and Disease. Genes, 8, Article 123. https://doi.org/10.3390/genes8040123
|
[7]
|
Poon, T.C.W., Wong, N., Lai, P.B.S., et al. (2006) A Tumor Progres-sion Model for Hepatocellular Carcinoma: Bioinformatic Analysis of Genomic Data. Gastroenterology, 131, 1262-1270. https://doi.org/10.1053/j.gastro.2006.08.014
|
[8]
|
Su, W.H., Chao, C.C., Yeh, S.H., et al. (2007) OncoDB.HCC: An Integrated Oncogenomic Database of Hepatocellular Carcinoma Revealed Aberrant Cancer Target Genes and Loci. Nucleic Acids Research, 35, D727-D731.
https://doi.org/10.1093/nar/gkl845
|
[9]
|
Kim, S., Li, Q., Dang, C.V. and Lee, L.A. (2000) Induction of Ribosomal Genes and Hepatocyte Hypertrophy by Adenovirus-Mediated Expression of c-Myc in Vivo. Proceedings of the National Academy of Sciences of the United States of America, 97, 11198-11202. https://www.pnas.org/doi/full/10.1073/pnas.200372597
https://doi.org/10.1073/pnas.200372597
|
[10]
|
Kawate, S., Fukusato, T., Ohwada, S., et al. (1999) Amplification of c-myc in Hepatocellular Carcinoma: Correlation with Clinicopathologic Features, Proliferative Activity and p53 Overex-pression. Oncology, 57, 157-163.
https://doi.org/10.1159/000012024
|
[11]
|
Dang, C.V. (2012) MYC on the Path to Cancer. Cell, 149, 22-35. https://doi.org/10.1016/j.cell.2012.03.003
|
[12]
|
Sanders, J.A. and Gruppuso, P.A. (2005) Nucleolar Localization of Hepatic c-Myc: A Potential Mechanism for c-Myc Regulation. Biochimica et Biophysica Acta (BBA)—Molecular Cell Research, 1743, 141-150.
https://doi.org/10.1016/j.bbamcr.2004.09.009
|
[13]
|
Ceni, E., Mello, T. and Galli, A. (2014) Pathogenesis of Alco-holic Liver Disease: Role of Oxidative Metabolism. World Journal of Gastroenterology, 20, 17756-17772. https://doi.org/10.3748/wjg.v20.i47.17756
|
[14]
|
Yilma, M., Saxena, V. and Mehta, N. (2022) Models to Predict Development or Recurence of Hepatocellular Carcinoma (HCC) in Patients with Advanced Hepatic Fibrosis. Current Gastroenterology Reports, 24, 1-9.
https://pubmed.ncbi.nlm.nih.gov/35142988/
https://doi.org/10.1007/s11894-022-00835-8
|
[15]
|
Nevzorova, Y.A., Cubero, F.J., Hu, W., et al. (2016) Enhanced Expression of c-myc in Hepatocytes Promotes Initiation and Progression of Alcoholic Liver Disease. Journal of Hepa-tology, 64, 628-640.
https://doi.org/10.1016/j.jhep.2015.11.005
|
[16]
|
Kaposi-Novak, P., Libbrecht, L., Woo, H.G., et al. (2009) Central Role of c-Myc during Malignant Conversion in Human Hepatocarcinogenesis. Cancer Research, 69, 2775-2782. https://doi.org/10.1158/0008-5472.CAN-08-3357
|
[17]
|
Jonghwan Kim, et al. (2010) A Myc Network Accounts for Similarities between Embryonic Stem and Cancer Cell Transcription Programs. Cell, 143, 313-324. https://pubmed.ncbi.nlm.nih.gov/20946988/
https://doi.org/10.1016/j.cell.2010.09.010
|
[18]
|
Attallah, A.M., El-Far, M., Omran, M.M., et al. (2016) GPC-HCC Model: A Combination of Glybican-3 with Other Routine Parameters Improves the Diagnostic Efficacy in Hepatocellular Carcinoma. Tumour Biology, 37, 12571-12577. https://doi.org/10.1007/s13277-016-5127-6
|
[19]
|
Shachaf, C.M., Kopelman, A.M., Arvanitis, C., et al. (2004) MYC Inactivation Uncovers Pluripotent Differentiation and Tumour Dor-mancy in Hepatocellular Cancer. Nature, 431, 1112-1117. https://doi.org/10.1038/nature03043
|
[20]
|
Beroukhim, R., Mermel, C.H., Porter, D., et al. (2010) The Landscape of Somatic Copy-Number Alteration across Human Cancers. Na-ture, 463, 899-905. https://doi.org/10.1038/nature08822
|
[21]
|
Niitsu, N., Okamoto, M., Miura, I. and Hirano, M. (2009) Clinical Features and Prognosis of De Novo Diffuse Large B-Cell Lymphoma with t(14;18) and 8q24/c-MYC Translocations. Leukemia, 23, 777-783.
https://doi.org/10.1038/leu.2008.344
|
[22]
|
Emre Seli, et al. (2005) An Embryonic Poly(A)-Binding Protein (ePAB) Is Expressed in Mouse Oocytes and Early Preimplantation Embryos. Proceedings of the National Academy of Sciences of the United States of America, 102, 367-372. https://pubmed.ncbi.nlm.nih.gov/15630085/
https://doi.org/10.1073/pnas.0408378102
|
[23]
|
Goss, D.J. and Kleiman, F.E. (2013) Poly(A) Binding Proteins: Are They All Created Equal? Wiley Interdisciplinary Reviews RNA, 4, 167-179. https://doi.org/10.1002/wrna.1151
|
[24]
|
Kühn, U. and Wahle, E. (2004) Structure and Function of Poly(A) Binding Proteins. Biochimica Et Biophysica Acta, 1678, 67-84.
|
[25]
|
Passmore, L.A. and Coller, J. (2022) Roles of mRNA Poly(A) Tails in Regulation of Eukaryotic Gene Expression. Nature Reviews Molecular Cell Biology, 23, 93-106. https://doi.org/10.1038/s41580-021-00417-y
|
[26]
|
Khanam, T., Muddashetty, R.S., Kahvejian, A., Sonenberg, N. and Brosius, J. (2006) Poly(A)-Binding Protein Binds to A-Rich Sequences via RNA-Binding Domains 1+2 and 3+4. RNA Biology, 3, 170-177.
https://pubmed.ncbi.nlm.nih.gov/17387282/
https://doi.org/10.4161/rna.3.4.4075
|
[27]
|
Zhu, Y.F. and Qi, M. (2020) Expression and Prognostic Roles of PABPC1 in Hepatocellular Carcinoma. International Journal of Surgery, 84, 3-12. https://doi.org/10.1016/j.ijsu.2020.10.004
|
[28]
|
Ozturk, S. (2019) The Translational Functions of Embryonic Poly(A)-Binding Protein during Gametogenesis and Early Embryo Development. Molecular Reproduction and Devel-opment, 86, 1548-1560. https://doi.org/10.1002/mrd.23253
|
[29]
|
Bernstein, P., Peltz, S.W. and Ross, J. (1989) The Poly(A)-Poly(A)-Binding Protein Complex Is a Major Determinant of mRNA Stability in Vitro. Molecular and Cellular Biology, 9, 659-670. https://pubmed.ncbi.nlm.nih.gov/2565532/
https://doi.org/10.1128/mcb.9.2.659-670.1989
|
[30]
|
Gorgoni, B. and Gray, N.K. (2004) The Roles of Cytoplasmic Poly(A)-Binding Proteins in Regulating Gene Expression: A Developmental Perspective. Briefings in Functional Ge-nomics & Proteomics, 3, 125-141.
https://doi.org/10.1093/bfgp/3.2.125
|
[31]
|
Sladic, R.T., Lagnado, C.A., Bagley, C.J. and Goodall, G.J. (2004) Hu-man PABP Binds AU-Rich RNA via RNA- Binding Domains 3 and 4. European Journal of Biochemistry, 271, 450-457.
https://pubmed.ncbi.nlm.nih.gov/14717712/
https://doi.org/10.1046/j.1432-1033.2003.03945.x
|
[32]
|
Yang, H., Duckett, C.S. and Lindsten, T. (1995) iPABP, an Inducible Poly(A)-Binding Protein Detected in Activated Human T Cells. Molecular and Cellular Biology, 15, 6770-6776. https://pubmed.ncbi.nlm.nih.gov/8524242/
https://doi.org/10.1128/MCB.15.12.6770
|
[33]
|
Oliveira, A.G., Oliveira, L.D., Cruz, M.V., et al. (2023) Interaction between Poly(A)-Binding Protein PABPC4 and Nuclear Receptor Corepressor NCoR1 Modulates a Metabolic Stress Response. The Journal of Biological Chemistry, 299, Article ID: 104702. https://doi.org/10.1016/j.jbc.2023.104702
|
[34]
|
Burgess, H.M., Richardson, W.A., Anderson, R.C., et al. (2011) Nuclear Relocalisation of Cytoplasmic Poly(A)- Binding Proteins PABP1 and PABP4 in Response to UV Irradiation Reveals mRNA-Dependent Export of Metazoan PABPs. Journal of Cell Science, 124, 3344-3355. https://doi.org/10.1242/jcs.087692
|
[35]
|
Xie, J., Wei, X. and Chen, Y. (2021) Loss of PABPC1 Is Compensated by Elevated PABPC4 and Correlates with Transcriptome Changes. Biochemistry. https://doi.org/10.1101/2021.02.07.430165
|
[36]
|
Jiang, X., Wang, G., Liu, Y., et al. (2021) A Novel Long Non-Coding RNA RP11-286H15.1 Represses Hepatocellular Carcinoma Progression by Promoting Ubiquitination of PABPC4. Cancer Letters, 499, 109-121.
https://doi.org/10.1016/j.canlet.2020.11.038
|
[37]
|
Liu, D., Yin, B., Wang, Q., et al. (2012) Cytoplasmic Poly(A) Binding Protein 4 Is Highly Expressed in Human Colorectal Cancer and Correlates with Better Prognosis. Journal of Genetics and Genomics, 39, 369-374.
https://doi.org/10.1016/j.jgg.2012.05.007
|
[38]
|
Guo, W., Li, J., Huang, H., et al. (2021) LncRNA PCIR Is an On-cogenic Driver via Strengthen the Binding of TAB3 and PABPC4 in Triple Negative Breast Cancer. Frontiers in Oncol-ogy, 11, Article 630300.
https://doi.org/10.3389/fonc.2021.630300
|
[39]
|
Gu, Y., Wei, X., Sun, Y., et al. (2019) miR-192-5p Silencing by Genetic Aberrations Is a Key Event in Hepatocellular Carcinomas with Cancer Stem Cell Features. Cancer Research, 79, 941-953.
https://doi.org/10.1158/0008-5472.CAN-18-1675
|
[40]
|
Kini, H.K., Kong, J. and Liebhaber, S.A. (2014) Cytoplas-mic Poly(A) Binding Protein C4 Serves a Critical Role in Erythroid Differentiation. Molecular and Cellular Biology, 34, 1300-1309. https://pubmed.ncbi.nlm.nih.gov/24469397/
https://doi.org/10.1128/MCB.01683-13
|